Knovea Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 1.00 Cr
- Company Age 5 Year, 7 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 132.22 Cr
- Satisfied Charges ₹ 33.50 Cr
- Revenue Growth -99.88%
- Profit Growth -118.48%
- Ebitda -114.10%
- Net Worth -16.50%
- Total Assets 186.97%
About Knovea Pharmaceutical
Knovea Pharmaceutical Private Limited (KPPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 February 2020 (Five years 7 days old ). Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹132.22 Cr. The company has closed loans amounting to ₹33.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anil Satwani, Sumit Gupta, and Rohit Mantri serve as directors at the Company.
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24110MP2020PTC050978
- Company No.
050978
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2020
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Knovea Pharmaceutical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumit Gupta  | Nominee Director | 17-Feb-2020 | Current |
| Rohit Mantri | Nominee Director | 17-Feb-2020 | Current |
| Anil Satwani | Director | 17-Feb-2020 | Current |
Financial Performance of Knovea Pharmaceutical.
Knovea Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 99.88% decrease. The company also saw a substantial fall in profitability, with a 118.48% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Knovea Pharmaceutical?
In 2023, Knovea Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nutriventia LimitedSumit Gupta is a mutual person
Symbiotec Zenfold Private LimitedAnil Satwani and Rohit Mantri are mutual person
- Symbiotec Pharmalab Private Limited
Anil Satwani and Rohit Mantri are mutual person
Molbio Diagnostics Private LimitedRohit Mantri is a mutual person
Enaltec Pharma Research Private LimitedSumit Gupta is a mutual person
Ganesh Consumer Products LimitedRohit Mantri is a mutual person
Charges (Loans)
₹132.22 Cr
₹33.50 Cr
Charges Breakdown by Lending Institutions
- Sbicap Trustee Company Limited : 132.22 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Sep 2022 | Sbicap Trustee Company Limited | ₹132.22 Cr | Open |
| 23 Sep 2021 | Axis Bank Limited | ₹33.50 Cr | Satisfied |
How Many Employees Work at Knovea Pharmaceutical?
Knovea Pharmaceutical has a workforce of 115 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Knovea Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Knovea Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.